Last updated on September 2018

A Trial to Investigate the Efficacy of Bendamustine in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Refractory to Rituximab.

Brief description of study

To compare the efficacy of bendamustine against treatment of physician's choice on progression-free survival in subjects with indolent B-cell NHL.

Detailed Study Description

To test whether bendamustine will improve progression-free survival in subjects with indolent B-cell NHL that did not respond (stable disease or progressive disease) to rituximab or a rituximab-containing regimen during or within 6 months of the last rituximab treatment compared to treatment of physican's choice.

Clinical Study Identifier: NCT01289223

Contact Investigators or Research Sites near you

Start Over

Margaret C Wilson

Princess Alexandra Hospital
Brisbane, Australia

Margaret C Wilson

Dr Ludmila Demitrovicova
Bratislava, Slovakia

Pratyush Giri, Dr

Royal Adelaide Hospital
Adelaide, Australia